Disorders of flushing

Comprehensive Therapy

Volumn 31, Issue 1, 2005, Pages 59-71

  Yale, Steven H ^a,b   Vasudeva, Shikha ^a   Mazza, Joseph J ^a   Rolak, Loren ^a   Arrowood, Jodi ^a   Stichert, Sara ^a   Stratman, Erik S ^a  

^a Saint Joseph's Hospital Wisconsin   (United States)

^b MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CALCITONIN; CEPHALOSPORIN; CHLORAMPHENICOL; CHLORPROPAMIDE; CLONIDINE; COTRIMOXAZOLE; CYTARABINE; DESMOPRESSIN; DIHYDROPYRIDINE; GABAPENTIN; GRISEOFULVIN; IMMUNOGLOBULIN; MEPACRINE; METRONIDAZOLE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE ANTAGONIST; PAROXETINE; PROSTAGLANDIN INHIBITOR; TOLBUTAMIDE; TRIMETREXATE; UNINDEXED DRUG; VANCOMYCIN; VENLAFAXINE;

ADRENERGIC ACTIVITY; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALLERGY; ANAMNESIS; ANAPHYLAXIS; AUTONOMIC DYSFUNCTION; AUTONOMIC DYSREFLEXIA; BREAST CANCER; CARCINOID; CARCINOID SYNDROME; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG TOLERANCE; ENDOCRINE DISEASE; ERYTHEMA; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; FLUSHING; FOOD INTAKE; GENETIC DISORDER; GENETIC POLYMORPHISM; HORMONAL REGULATION; HORMONE SYNTHESIS; HOT FLUSH; HUMAN; HYPERHIDROSIS; HYPERSENSITIVITY; INTOXICATION; MASTOCYTOSIS; MENOPAUSAL SYNDROME; MENTAL DISEASE; NEUROENDOCRINE TUMOR; NEUROLOGIC DISEASE; OCCUPATIONAL EXPOSURE; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; REVIEW; ROSACEA; SIDE EFFECT; SKIN DISEASE; TESTOSTERONE SYNTHESIS; THYROID MEDULLARY CARCINOMA; VASOCONSTRICTION; VASODILATATION; VENOUS THROMBOEMBOLISM;

EID: 26244445570     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1385/comp:31:1:059     Document Type: Review

References (135)

1. Wilkin JK, Wilkin O, Kapp R, Donachie R, Chernosky ME, Buckner J. Aspirin blocks nicotinic acid-induced flushing. Clin Pharmacol Ther 1982;31:478-482.
2. Eriksson CJ. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol Clin Exp Res 2001;25:15S-32S.
3. Guivernau M, Baraona E, Lieber CS. Acute and chronic effects of ethanol and its metabolites on vascular production of prostacyclin in rats. J Pharmacol Exp Ther 1987;240:59-64.
4. Norheim I, Theodorsson-Norheim E, Brodin E, Oberg K. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush. J Clin Endocrinol Metab 1986;63:605-612.
5. Wilkin JK. Why is flushing limited to a mostly facial cutaneous distribution? J Am Acad Dermatol 1988;19:309-13.
6. Drummond PD. Sweating and vascular responses in the face: normal regulation and dysfunction in migraine, cluster headache and Harlequin syndrome. Clin Auton Res 1994;4:273-285.
7. Young WF, Jr, Maddox DE. Spells: in search of a cause. Mayo Clin Proc 1995;70:757-765.
8. Drummond PD, Lance JW. Facial flushing and sweating mediated by the sympathetic nervous system. Brain 1987;110(Pt 3):793-803.
9. Hendy MS, Cockrill B, Burge PS. The effects of naloxone infusion and stellate ganglion blockade on hot flushes in the human male. Maturitas 1985;7:169-174.
10. Freeman R, Waldorf HA, Dover JS. Autonomic neurodermatology (Part II): disorders of sweating and flushing. Semin Neurol 1992;12:394-407.
11. Parodi A, Guarrera M, Rebora A. Flushing in rosacea: an experimental approach. Arch Dermatol Res 1980;269:269-273.
12. Bernstein JE, Soltani K. Alcohol-induced rosacea flushing blocked by naloxone. Br J Dermatol 1982;107:59-61.
13. Cohen RA, Coffman JD. Naloxone reversal of morphine-induced peripheral vasodilatation. Clin Pharmacol Ther 1980;28:541-544.
14. Brandt NJ, Terenius L, Jacobsen BB, et al. Hyper-endorphin syndrome in a child with necrotizing encephalomyelopathy. N Engl J Med 1980;303:914-916.
15. Goldstein DJ, Keiser HR. A case of episodic flushing and organic psychosis: reversal by opiate antagonists. Ann Intern Med 1983;98:30-34.
16. Baraniuk JN, Murray RB, Mabbee WG. Naloxone, ethanol, and the chlorpropamide alcohol flush. Alcohol Clin Exp Res 1987;11:518-520.
17. Leslie RD, Pyke DA, Stubbs WA. Sensitivity to enkephalin as a cause of non-insulin dependent diabetes. Lancet 1979;1:341-343.
18. Dahl MV. Pathogenesis of rosacea. Adv Dermatol 2001;17:29-45.
19. Zuber TJ. Rosacea. Prim Care 2000;27:309-318.
20. Robson KJ, Piette WW. Cutaneous manifestations of systemic diseases. Med Clin North Am 1998;82:1359-1379, vi-vii.
21. Rebora A. The management of rosacea. Am J Clin Dermatol 2002;3:489-496.
22. Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res 1989;281:66-72.
23. Miller NS, Goodwin DW, Jones FC, et al. Histamine receptor antagonism of intolerance to alcohol in the Oriental population. J Nerv Ment Dis 1987;175:661-667.
24. Yoshida A. Genetic polymorphisms of alcohol metabolizing enzymes related to alcohol sensitivity and alcoholic diseases. Alcohol Alcohol 1994;29:693-696.
25. Ho SB, DeMaster EG, Shafer RB, et al. Opiate antagonist nalmefene inhibits ethanol-induced flushing in Asians: a preliminary study. Alcohol Clin Exp Res 1988;12:705-712.
26. Zimatkin SM, Anichtchik OV. Alcohol-histamine interactions. Alcohol Alcohol 1999;34:141-147.
27. Takeshita T, Mao XQ, Morimoto K. The contribution of polymorphism in the alcohol dehydrogenase beta subunit to alcohol sensitivity in a Japanese population. Hum Genet 1996;97:409-413.
28. Chen WJ, Chen CC, Yu JM, Cheng AT. Self-reported flushing and genotypes of ALDH2, ADH2, and ADH3 among Taiwanese Han. Alcohol Clin Exp Res 1998;22:1048-1052.
29. Crabb DW, Dipple KM, Thomasson HR. Alcohol sensitivity, alcohol metabolism, risk of alcoholism, and the role of alcohol and aldehyde dehydrogenase genotypes. J Lab Clin Med 1993;122:234-240.
30. Hatake K, Taniguchi T, Ouchi H, Sakaki N, Hishida S, Ijiri I. Possible involvement of kinins in cardiovascular changes after alcohol intake. Pharmacol Biochem Behav 1990;35:437-442.
31. Settipane GA. The restaurant syndromes. N Engl Reg Allergy Proc 1987;8:39-46.
32. Miller NS, Goodwin DW, Jones FC, et al. Antihistamine blockade of alcohol-induced flushing in Orientals. J Stud Alcohol 1988; 49:16-20.
33. Truitt EB, Jr, Gaynor CR, Mehl DL. Aspirin attenuation of alcohol-induced flushing and intoxication in Oriental and Occidental subjects. Alcohol Alcohol 1987;(Suppl 1):595-599[Note1].
34. Tan OT, Stafford TJ, Sarkany I, Gaylarde PM, Tilsey C, Payne JP. Suppression of alcohol-induced flushing by a combination of H1 and H2 histamine antagonists. Br J Dermatol 1982;107:647-652.
35. Johnston C, Saunders JB, Barnett AH, Ricciardi BR, Hopkinson DA, Pyke DA. Chlorpropamide-alcohol flush reaction and isoenzyme profiles of alcohol dehydrogenase and aldehyde dehydrogenase. Clin Sci (Lond) 1986;71:513-517.
36. Gill K, Eagle Elk M, Liu Y, Deitrich RA. An examination of ALDH2 genotypes, alcohol metabolism and the flushing response in Native Americans. J Stud Alcohol 1999;60:149-158.
37. Sauter AM, Boss D, von Wartburg JP. Reevaluation of the disulfiram-alcohol reaction in man. J Stud Alcohol 1977;38:1680-1695.
38. Walsh B, Schiff I. Vasomotor flushes. Ann N Y Acad Sci 1990;592:346-356; discussion 390-394.
39. Bider D, Mashiach S, Serr DM, Ben-Rafael Z. Endocrinological basis of hot flushes. Obstet Gynecol Surv 1989;44:495-499.
40. Charig CR, Rundle JS. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology 1989;33:175-178.
41. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990;592:52-86; discussion 123-133.
42. Mulley G, Mitchell JR, Tattersall RB. Hot flushes after hypophysectomy. Br Med J 1977;2:1062.
43. Wyon Y, Frisk J, Lundeberg T, Theodorsson E, Hammar M. Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide. Maturitas 1998;30:289-294.
44. Lightman SL, Jacobs HS, Maguire AK, McGarrick G, Jeffcoate SL. Climacteric flushing: clinical and endocrine response to infusion of naloxone. Br J Obstet Gynaecol 1981;88:919-924.
45. Smith JA, Jr. Management of hot flushes due to endocrine therapy for prostate carcinoma. Oncology (Huntingt) 1996;10:1319-1322; discussion 1324.
46. Casper RF, Yen SS. Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxf) 1985;22:293-312.
47. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;288:872-881.
48. Smith JA, Jr. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate. J Urol 1994;152:132-134.
49. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994;331:347-352.
50. Sicat BL, Brokaw DK. Nonhormonal alternatives for the treatment of hot flashes. Pharmacotherapy 2004;24:79-93.
51. Cox NH, Mustchin CP. Prolonged spontaneous and alcohol-induced flushing due to the solvent dimethylformamide. Contact Dermatitis 1991;24:69-70.
52. Mooney E. The flushing patient. Int J Dermatol 1985;24:549-554.
53. Friedman AJ, Juneau-Norcross M, Rein MS. Adverse effects of leuprolide acetate depot treatment. Fertil Steril 1993;59:448-450.
54. Pau AK, Khakoo R. "Red-neck syndrome" with slow infusion of vancomycin. N Engl J Med 1985;313:756,757.
55. Wallace MR, Mascola JR, Oldfield EC, III. Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis 1991;164:1180-1185.
56. Osterloh I. The safety of amlodipine. Am Heart J 1989;118:1114-1119; discussion 1119,1120.
57. Polk RE. Anaphylactoid reactions to glycopeptide antibiotics. J Antimicrob Chemother 1991;27(Suppl B):17-29.
58. Ngeow WC, Chai WL, Moody AB. Red man syndrome during administration of prophylactic antibiotic against infective endocarditis. J Ir Dent Assoc 2000;46:92-94.
59. Pieper JA. Understanding niacin formulations. Am J Manag Care 2002;8:S308-S314.
60. Reid JL, Wing LM, Dargie HJ, Hamilton CA, Davies DS, Dollery CT. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet 1977;1:1171-1174.
61. Hoskins PJ, Wiles PG, Volkmann HP, Pyke DA. Chlorpropamide alcohol flushing: a normal response? Clin Sci (Lond) 1987;73:77-80.
62. Capretti L, Speroni G, Girone M, Coscelli C, Butturini U, Rocca G. Chlorpropamide- and tolbutamide-alcohol flushing in non-insulin-dependent diabetes. Br Med J (Clin Res Ed) 1981;283:1361,1362.
63. Johnston C, Wiles PG, Pyke DA. Chlorpropamide - alcohol flush: the case in favour. Diabetologia 1984;26:1-5.
64. Kobberling J, Bengsch N, Bruggeboes B, Schwarck H, Tillil H, Weber M. The chlorpropamide alcohol flush. Lack of specificity for familial non-insulin dependent diabetes. Diabetologia 1980;19:359-363.
65. Micossi P. The prevalence of chlorpropamide alcohol flushing in non-insulin dependent diabetics. Diabetologia 1981;20:510.
66. Lipp A, Tang A, Wiles PG. Chlorpropamide alcohol flushing at high chlorpropamide dose is not specific for non-insulin dependent diabetes. Horm Metab Res 1985;17:480.
67. Barnett AH, Gonzalez-Auvert C, Pyke DA, et al. Blood concentrations of acetaldehyde during chlorpropamide-alcohol flush. Br Med J (Clin Res Ed) 1981;283:939-941.
68. Ohlin H, Jerntorp P, Bergstrom B, Almer LO. Chlorpropamide-alcohol flushing, aldehyde dehydrogenase activity, and diabetic complications. Br Med J (Clin Res Ed) 1982;285:838-840.
69. Johnston C, Wiles PG, Medbak S, et al. The role of endogenous opioids in the chlorpropamide alcohol flush. Clin Endocrinol (Oxf) 1984;21:489-497.
70. Jerntorp P, Almer LO, Melander A. Is the blood chlorpropamide concentration critical in chlorpropamide alcohol flush? Lancet 1981;1:165,166.
71. Johnston C, Carey F, Forder RA, Haworth D. Prostacyclin and thromboxane in non-insulin dependent diabetes: the chlorpropamide alcohol flush reaction revisited. Clin Sci (Lond) 1984;67:633-638.
72. Medbak S, Wass JA, Clement-Jones V, et al. Chlorpropamide alcohol flush and circulating met-enkephalin: a positive link. Br Med J (Clin Res Ed) 1981;283:937-939.
73. Strakosch CR, Jefferys DB, Keen H. Blockade of chlorpropamide alcohol flush by aspirin. Lancet 1980;1:394-396.
74. Groop L, Eriksson CJ, Wahlin-Boll E, Melander A. Chlorpropamide-alcohol flush: significance of body weight, sex and serum chlorpropamide level. Eur J Clin Pharmacol 1984;26:723-725.
75. Hillson RM, Smith RF, Dhar H, Moore RA, Hockaday TD. Chlorpropamide- alcohol flushing and plasma chlorpropamide concentrations in diabetic patients on maintenance chlorpropamide therapy. Diabetologia 1983;24:210-212.
76. Scher W, Scher BM. A possible role for nitric oxide in glutamate (MSG)-induced Chinese restaurant syndrome, glutamate-induced asthma, 'hot-dog headache', pugilistic Alzheimer's disease, and other disorders. Med Hypotheses 1992;38:185-188.
77. Gann D. Ventricular tachycardia in a patient with the "Chinese restaurant syndrome". South Med J 1977;70:879-881.
78. Mohyi D, Tabassi K, Simon J. Differential diagnosis of hot flashes. Maturitas 1997;27:203-214.
79. Michils A, Vandermoten G, Duchateau J, Yernault JC. Anaphylaxis with sodium benzoate. Lancet 1991;337:1424,1425.
80. Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. Arch Intern Med 1999;159:670-674.
81. Aksamit TR, Floras JS, Victor RG, Aylward PE. Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans. Hypertension 1987;9:309-314.
82. Tiensuu Janson EM, Oberg KE. Carcinoid tumours. Baillieres Clin Gastroenterol 1996;10:589-601.
83. Crasset V, Delcourt E. Facial flushes and diarrhoea. Postgrad Med J 1997;73:337,338.
84. Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 2001;12(Suppl 2):S95-S99.
85. Vinik AI, Thompson N, Eckhauser F, Moattari AR. Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. Acta Oncol 1989;28:389-402.
86. Feldman JM, Jones RS. Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis. Ann Surg 1982;196:33-37.
87. Maton PN. The carcinoid syndrome. JAMA 1988;260:1602-1605.
88. Solcia E, Fiocca R, Rindi G, et al. Endocrine tumors of the small and large intestine. Pathol Res Pract 1995;191:366-372.
89. Robertson JI. Carcinoid syndrome and serotonin: therapeutic effects of ketanserin. Cardiovasc Drugs Ther 1990;4(Suppl)1:53-58.
90. Gustafsen J, Boesby S, Nielsen F, Giese J. Bradykinin in carcinoid syndrome. Gut 1987;28:1417-1419.
91. Grahame-Smith DG. What is the cause of the carcinoid flush? Gut 1987;28:1413-1416.
92. Onaitis MW, Kirshbom PM, Hayward TZ, et al. Gastrointestinal carcinoids: characterization by site of origin and hormone production. Ann Surg 2000;232:549-556.
93. Conlon JM, Deacon CF, Richter G, Stockmann F, Creutzfeldt W. Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol 1987;22:97-105.
94. Schaffalitzky De Muckadell OB, Aggestrup S, Stentoft P. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man. Scand J Gastroenterol 1986;21:498-502.
95. Shakir KM, Jasser MZ, Yoshihashi AK, Drake AJ, III, Eisold JF. Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy. Mayo Clin Proc 1996;71:1145-1149.
96. Lewis RA. Mastocytosis. J Allergy Clin Immunol 1984;74:755-765.
97. Castells M, Austen KF. Mastocytosis: mediator-related signs and symptoms. Int Arch Allergy Immunol 2002;127:147-152.
98. Shome GP, Nangia R, Baldwin JL. Flushing and syncopal episode in a 47-year-old female. Ann Allergy Asthma Immunol 2001;86:161-165.
99. Korenblat PE, Wedner HJ, Whyte MP, Frankel S, Avioli LV. Systemic mastocytosis. Arch Intern Med 1984;144:2249-2253.
100. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-1626.
101. Tebbe B, Stavropoulos PG, Krasagakis K, Orfanos CE. Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations. Dermatology 1998;197:101-108.
102. Frieri M, Alling DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial. Am J Med 1985;78:9-14.
103. Pleet AB. Funny spells in neuroendocrine disorders. Semin Neurol 1995;15:133-150.
104. Wells SA, Jr, Dilley WG, Farndon JA, Leight GS, Baylin SB. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 1985;145:1248-1252.
105. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002;287:1427-1434.
106. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001;134:315-329.
107. Sawka AM, Jaeschke R, Singh RJ, Young WF, Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003;88:553-558.
108. Oberg K. State of the art and future prospects in the management of neuroendocrine tumors. Q J Nucl Med 2000;44:3-12.
109. Philippe J. APUDomas: acute complications and their medical management. Baillieres Clin Endocrinol Metab 1992;6:217-228.
110. Kebebew E, Clark OH. Medullary thyroid cancer. Curr Treat Options Oncol 2000;1:359-367.
111. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986;315:663-666.
112. Smart DR. Scromboid poisoning. A report of seven cases involving the Western Australian salmon, Arripis truttaceus. Med J Aust 1992;157:748-751.
113. Morrow JD, Margolies GR, Rowland J, Roberts LJ, II. Evidence that histamine is the causative toxin of scromboid-fish poisoning. N Engl J Med 1991;324:716-720.
114. Becker K, Southwick K, Reardon J, Berg R, MacCormack JN. Histamine poisoning associated with eating tuna burgers. JAMA 2001;285:1327-1330.
115. Merson MH, Baine WB, Gangarosa EJ, Swanson RC. Scromboid fish poisoning. Outbreak traced to commercially canned tuna fish. JAMA 1974;228:1268,1269.
116. Zalzal GH. Congenital gustatory facial flushing. Otolaryngol Head Neck Surg 1991;104:878-880.
117. Dizon MV, Fischer G, Jopp-McKay A, Treadwell PW, Paller AS. Localized facial flushing in infancy. Auriculotemporal nerve (Frey) syndrome. Arch Dermatol 1997;133:1143-1145.
118. Drummond PD. Mechanism of gustatory flushing in Frey's syndrome. Clin Auton Res 2002;12:144-146.
119. Drummond PD, Boyce GM, Lance JW. Postherpetic gustatory flushing and sweating. Ann Neurol 1987;21:559-63.
120. Drummond PD, Lance JW. Site of autonomic deficit in Harlequin syndrome: local autonomic failure affecting the arm and the face. Ann Neurol 1993;34:814-819.
121. Lance JW, Drummond PD, Gandevia SC, Morris JG. Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry 1988;51:635-642.
122. Turco GR, Farber NE. Postoperative autonomic deficit: a case of harlequin syndrome. Anesthesiology 1996;85:1197-1199.
123. Morrison DA, Bibby K, Woodruff G. The "Harlequin" sign and congenital Horner's syndrome. J Neurol Neurosurg Psychiatry 1997;62:626-628.
124. Metz SA, Halter JB, Porte D, Jr, Robertson RP. Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing. Ann Intern Med 1978;88:189-193.
125. Colachis SC, III. Autonomic hyperreflexia with spinal cord injury. J Am Paraplegia Soc 1992;15:171-186.
126. Doan T, Greenberger PA. Nearly fatal episodes of hypotension, flushing, and dyspnea in a 47-year-old woman. Ann Allergy 1993;70:439-444.
127. Holter G, Irgens A, Nyfors A, et al. Self-reported skin and respiratory symptoms related to latex exposure among 5,087 hospital employees in Norway. Dermatology 2002;205:28-31.
128. Ranta PM, Ownby DR. A review of natural-rubber latex allergy in health care workers. Clin Infect Dis 2004;38:252-256.
129. Friedman BS, Germano P, Miletti J, Metcalfe DD. A clinicopathologic study of ten patients with recurrent unexplained flushing. J Allergy Clin Immunol 1994;93:53-60.
130. Aldrich LB, Moattari AR, Vinik AI. Distinguishing features of idiopathic flushing and carcinoid syndrome. Arch Intern Med 1988;148:2614-2618.
131. Murray AH. Differential diagnosis of a red face. J Cutan Med Surg 1998;2(Suppl 4):S4-11-5.
132. McCallum KA, Reading C. Hot flushes are induced by thermogenic stimuli. Br J Urol 1989;64:507-510.
133. Loprinzi CL, Goldberg RM, O'Fallon JR, et al. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol 1994;151:634-636.
134. Whitfield JB, Martin NG. Aversive reactions and alcohol use in Europeans. Alcohol Clin Exp Res 1993;17:131-134.
135. Goetz CG. Textbook of Neurology (electronic version). Saunders Philadelphia, P A, 2003, 389.